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As the first identified scorpion toxin active on both big conductance Ca 2+ -activated K + channels (BK) and small conductance Ca
2+
-activated K + channels (SK), BmBKTx1 has been proposed to have two separate functional faces for two targets. To investigate this hypothesis, two double mutants, K21A-Y30A and R9A-K11A, together with wild-type toxin were expressed in Escherichia coli. The recombinant toxins were tested on cockroach BK and rat SK2 channel for functional assay. Mutant K21A-Y30A had a dramatic loss of function on BK but retained its function on SK. Mutant R9A-K11A did not lose function on BK or SK. These data support the two functional-face hypothesis and indicate that the BK face is on the C-terminal β-sheet.
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BmBKTx1; scorpion K + channel toxin (KTx); K + channel; two functional faces Scorpion toxins are valuable pharmacological tools for studies on the structure and function of potassium channels. The interaction modes of scorpion K + channel toxins (KTxs) and K + channels have been classified into three types: (1) pore area block, (2) intermediate area block and (3) turret area block [1] . Pore block toxins often act on the voltage-gated K + channels (Kvs) and big conductance Ca 2+ -activated K + channels (BKs). They bind to the channel pore and use a basic residue side chain to directly clog the K + flux pathway. Intermediate area block toxins are smaller in size; they interact with small conductance Ca 2+ -activated K + channels (SKs) on the pore and turret areas. Charge-charge interaction is the primary interaction force for the SK toxin docking. The type 3 turret block toxins interact with HERG channels. Their binding sites are located at the turret area, away from the central pore, and the interaction occurs with two heads of the toxin molecule [2] .
It is quite common for one scorpion KTx to have multiple K + channel blocking activities. However, it has rarely been reported that one KTx has multiple interaction faces for different channels. In 2004, Regaya et al confirmed the existence of distinct functional faces in scorpion toxin [3] . BmTx3 is the first reported scorpion KTx to have type 1 and type 3 functional faces responsible for A-type and HERG K + current activity, respectively [4], while BmBKTx1 is the first KTx proposed to have type 1 and type 2 faces for BK and SK function, respectively [5] .
In this work, the two functional faces of BmBKTx1 were studied by mutagenesis. Two double mutants, K21A-Y30A and R9A-K11A, together with wild-type (WT) toxin were expressed and tested on cockroach BK channel (pSlo) and rat SK2 (rSK2) channel. The functional data prove the existence and importance of the two functional faces, and indicate that the BK face is on the C-terminal β-sheet.
Materials and Methods
Expression and purification of recombinant toxins WT and mutant BmBKTx1 was expressed in Escherichia coli as a C-terminal fusion to a glutathione S-transferase (GST) tag in the pGEX 4T-1 vector. The fusion protein was induced at 37 ºC for 3 h with 0.4 mM isopropyl β-D-thiogalactopyranoside (IPTG), and purified by a glutathione-agarose (GSH) column (Amersham Biosciences, Piscataway, USA). The fusion protein was then digested by Factor Xa (New England Biolabs, Ipswich, USA) at 23 ºC for 12 h in a digestion buffer containing 20 mM Tris-HCl, 100 mM NaCl and 2 mM CaCl 2 (pH 8.0).
The cleavage products were loaded onto a GSH column to separate the recombinant toxins from the GST tag and uncleaved fusion proteins. The recombinant toxins were then purified to a high homogenecity on a reverse-phase high-performance liquid chromatography (HPLC) Zorbax C18 column (Agilent, Palo Alto, USA).
Verification of the correct folding of the recombinant toxins
The hydrophobicity of the recombinant toxins was compared with that of previously synthesized BmBKTx1 by passing them through the Zorbax C18 column [5] . The elution gradient: 20% to 50% buffer B (0.1% trifluoroacetic acid in acetonitrile) in 20 min.
Circular dichroism (CD) spectroscopy
Samples for CD spectroscopy were dissolved in 10mM phosphate buffer, pH 7.0. The final concentration of the samples was 0.8 mg/ml for R9A-K11A, 1 mg/ml for WT and 1.2 mg/ml for K21A-Y30A. Spectra were obtained on a Jasco J-715 spectrometer in 1 mm cells at 20 ºC. The results were analyzed with standard analysis software (Jasco, Tokyo, Japan).
Functional assay of recombinant toxins
For electrophysiology, pSlo and rSK2 channels were transiently expressed in HEK293 cells [5] . Cells were cultured at a density of ~2×10 4 /35 mm dish and transfected with 1 μg of channel DNA (Slo: pSlo/pcDNA3.1 (splice variant AAAA); SK: rSK2/pcDNA3.1) and 0.5 μg of pEGFP-C1 (Clontech Laboratories Inc, Palo Alto, USA) using Roti-Fect transfection kit (Roth, Karlsruhe, Germany).
Whole-cell ion currents in HEK293 cells expressing pSlo or SK were measured at room temperature using a whole-cell patch-clamp that appropriately compensated series resistance and capacitive currents. Current measurements and data acquisition were performed with an EPC9 patch-clamp amplifier (HEKA Elektronik, Lambrecht, Germany), which was controlled by PatchMaster software (HEKA Elektronik).
The bath solution for measuring Slo currents contained: 135 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 0.33 mM NaH 2 PO 4 , 2 mM Na-pyruvate, 10 mM glucose, 10 mM HEPES. For measuring SK currents, the bath solution differed and contained 110 mM NaCl and 30 mM KCl. The pipette solution contained 140 mM KCl, 4 mM NaCl, 2 mM Mg-ATP, and 10 mM HEPES. The free Ca 2+ concentration of pipette solutions was measured with calcium-sensitive electrodes (KWIK tips; WPI, Berlin, Germany), and was adjusted to 2.5 μM to measure SK currents and to 25 μM to measure Slo currents. The pH of the bath solution and pipette solution was adjusted to 7.4 and 7.25, respectively. Liquid junction potentials between the pipette and bath solutions were taken into account before establishing the seal. The holding potentials for Slo and SK current measurements were −90 mV and −40 mV, and the K + equilibrium potentials amounted to −84 mV and −40 mV, respectively.
For toxin application the bath perfusion system BPS4 (ALA, Westbury, USA) was used.
Results

Design of BmBKTx1 mutants
To investigate the functional faces of BmBKTx1 for BK and SK channels, we aligned the sequences of scorpion BK and SK toxins with BmBKTx1 [ Fig. 1(A) ]. Most of the BK toxins are active on Kv channels as well, and their Kv functional sites have been studied extensively [6−12]. The BK (and/or Kv) toxin functional residues cluster on the C-terminal β sheet face, and a conserved functional dyad (Lys-Tyr) plays a central role in their blocking activity. By contrast, SK toxin functional residues, all of which are basic residues, are found on the N-terminal α-helix face [13−15]. Although they belong to the same superfamily, BK and SK channels show low homology in the pore region, which may provide an evolutional reason to explain the development of scorpion toxins with diverse functional faces [ Fig. 1 
(B)].
BmBKTx1 is shorter than other BK toxins, but it is the same size as SK toxins. It contains the conserved dyad (K21-Y30) in its C-terminus, which is why it was chosen as the mutation sites for BK function. There are no basic residues in BmBKTx1 on the conventional SK sites. Two neighboring basic residues (R9-K11) of BmBKTx1 were mutated to investigate the SK functional face.
Expression and purification of recombinant toxins
In order to obtain high expression yield, we optimized the induction temperature (18−37 ºC), the induction time (2− 18 h) and the IPTG concentration (0.2−0.8 mM). The channels; Kv, voltage-gated K + channels; SK, small conductance Ca 2+ -activated K + channels. Black denotes the same amino acid residues in the primary structure of these channels; gray denotes the similar amino acid residues in the primary structure of these channels. best condition to induce the cells was at 37 ºC for 3 h with 0.4 mM IPTG [ Fig. 2(A) ].
The GST-BmBKTx1 fusion proteins were cleaved by Factor Xa, which has a high cleavage efficiency. Another advantage of Factor Xa is that it leaves no additional residues on the target protein after cleavage. As shown in Fig. 2(B) , more than 90% of GST-BmBKTx1 fusion protein was cleaved after 12 h of digestion in Factor Xa at 23 ºC [ Fig. 2(B) ].
The recombinant toxins were purified to a high homogeneity by reverse-phase HPLC [ Fig. 2(C)] , and then lyophilized. The molecular weights of the recombinant toxins determined by mass spectroscopy were consistent with their theoretical values [ Fig. 2(C) and Table 1 ]. The final yields of the recombinant toxins were almost 6 mg per liter, which is a substantial improvement over previous studies [16, 17] .
In order to verify the folding of the recombinant toxins, the fully functional synthetic BmBKTx1 was used as a reference to test whether the recombinant BmBKTx1 had the same hydrophobicity as the synthetic one [5] . Both synthetic and recombinant BmBKTx1 were eluted at the same time on the same reverse-phase HPLC C18 column [ Fig. 3(A,B) ]. Equal amounts of the recombinant and synthetic toxins were then premixed and loaded onto the same C18 column again [ Fig. 3(C) ]. Only one elution peak was observed, indicating that the two samples have the same characteristics. The functional assay also confirmed that the recombinant toxins had the same function as the native one [5] . 
Table 1 Sequences and molecular weights (MW) of recombinant toxins
The marked "A" in K21A-Y30A and R9A-K11A denote the substitution of relative amino acid residues by alanine.
of K21A-Y30A mutant's BK blocking function does not result from mutation-induced conformational changes.
Activity assay of recombinant toxins
An earlier study demonstrated that BmBKTx1 effectively blocks pSlo [5] . Here we first tested whether its mutation--a mutation of the basic residues R9 and K11 of toxin R9A-K11A--would likewise affect toxin action (Fig. 5,  left) . Compared with the concentration-dependent recombinant WT toxin, there was no significant difference in the R9A-K11A mutant's effect [ Fig. 5(B) , left]. However, the mutation of K21A and Y30A (K21A-Y30A) in the Cterminal β-sheet region of BmBKTx1 caused a dramatic loss of blocking potency (Fig. 5, left) . At 10 μM, the WT toxin reduced pSlo currents to 0.19±0.08 of control (n=6) and R9A-K11A to 0.24±0.05 of control (n=6). K21A-Y30A reduced the current to only 0.56±0.07 of control (n=6), which differs significantly from both other WT and R9A-K11A recombinant toxins (P<0.01). Furthermore, the effects of the toxin develop more slowly for K21A-Y30A mutant [ Fig. 5(C) , left]. The time constant describing the time course of toxin block (1 μM) is 161 s for R9A-K11A mutant and 210 s for K21A-Y30A mutant. In contrast to pSlo, there is no difference in the action of R9A-K11A and K21A-Y30A on rSK2 (Fig. 5, right) . There is neither a significant difference in its blocking efficiency nor in its time course [ Fig. 5(B,C) , right]. The activities of the two mutants on rSK2 are comparable to the WT toxin [5] . The secondary structure of rBmBKTx1 and its two mutants were also examined by CD spectroscopy (Fig. 4) . There were no differences in the secondary structures among these three peptides, which indicates that the loss 
Discussion
The interaction of BmBKTx1 and BK channels Dauplais et al proposed the idea that potassium channelblocking toxins with unrelated structures have a conservative functional dyad composed of a Lys residue and an aromatic residue (tyrosine or Phe) [18] . Breaking this dyad will result in the loss of channel block activity. Mouhat et al modified this theory in 2005 [19] . In the new hypothesis, toxins first recognize the various Kv1 channel subtypes through various sets of residues distinct from the functional dyad; the functional dyad then potentially serves as a supplementary anchoring point and a first efficient physical barrier. In BmBKTx1, the conserved dyads (K21 and Y30) were found in the Cterminal β-sheet face. As expected, the dyad mutation substantially reduced pSlo's blocking potency and slowed the development of the blocking effect. It is interesting to note that the K21 side chain points out from the β-sheet surface, while the Y30 side chain is in a parallel position to the β-sheet [ Fig. 6(B) ]; this suggests that they might have different interaction sites on pSlo [20] . Based on the Streptomyces lividans K + channel (KcSA) structure [21] , the pore region structure of the pSlo channel was modeled by the Swiss-model server (http://swissmodel.expasy.org/SWISS-MODEL.html) [ Fig. 6(A) ]. Based on the other Kv blocking models [1], we propose that the K21 side chain might directly dip into the channel pore by interacting with pSlo D281 via charge-charge interaction and by forming hydrogen bonds with neighboring residues such as Y279 and Y283. The residues Y268 and F269 from four pSlo subunits form a hydrophobic ring on the pore entrance, which might interact with the Y30 of BmBKTx1 via hydrophobic interaction. 
The interaction of BmBKTx1 and SK channels
It has been reported that three basic residues (R6, R7 and R13) located at the α-helix face of the toxins are crucial for SK blocking [13] . In BmBKTx1, there are no basic residues on these sites, and Arg9 and Lys11 are the only basic residues on the α-helix face. The mutation of R9 and K11 to alanine does not affect the SK function, suggesting that BmBKTx1 might have an unconventional form of interaction with SK channels. We compared the structure of BmBKTx1 with that of SK toxins P05 and LeTXI [ Fig. 6(C-E) ]. The functional amino acid residues in P05 (R6, R7 and R13) and in LeTxI (R6 and R13) are fully exposed on the surface, point in the same direction and form a positive charge pincer [22, 23] . Although R9 and K11 in BmBKTx1 are also exposed on the surface, they point in opposite directions and thus do not form a positive charge pincer. Furthermore, compared with other SK toxins, the two basic residues of BmBKTx1 (R9 and K11) are too close to each other, so they might not be capable of contacting the corresponding binding sites of the SK channel in conformation. This difference may explain why R9 and K11 are not functional sites for SK, and it also further supports the notion that the scorpion toxin function is precisely regulated by its residue type and side chain orientation.
Two separate functional faces for BK and SK
Although the SK functional face has not been determined, the hypothesis that BmBKTx1 has two separate functional faces has been substantially supported by this study. The fact that the mutation of dyad residue K21-Y30 dramatically affects the BK function but not the SK function indicates that BK and SK functional faces are fully separated. BmBKTx1's BK functional face is located on the C-terminal β-sheet; we predict that the SK face might be on the N-terminal α-helix, on which other residues (besides the basic residues R9 and K11) are the primary interaction sites with SK channels. Future research will be necessary to find the functional residues for SK blocking activity.
Concluding remarks
In this study, we established a high-yield system for expression and purification of rBmBKTx1 and its mutants. Our data validated the existence and importance of the conservative dyad of functional residues and proved the hypothesis of separated functional faces in one toxin. The multi-functional face phenomenon may have a general 
